Signature Wealth Management Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,529
Closed -$419K 114
2025
Q1
$419K Buy
16,529
+8,800
+114% +$230K 0.27% 67
2024
Q4
$205K Hold
7,729
0.14% 98
2024
Q3
$224K Sell
7,729
-768
-9% -$22.4K 0.16% 94
2024
Q2
$238K Sell
8,497
-9,400
-53% -$259K 0.18% 91
2024
Q1
$497K Sell
17,897
-500
-3% -$13.9K 0.4% 54
2023
Q4
$530K Sell
18,397
-607
-3% -$18.3K 0.46% 47
2023
Q3
$630K Buy
19,004
+1,700
+10% +$60.1K 0.62% 39
2023
Q2
$635K Buy
17,304
+7,875
+84% +$307K 0.59% 43
2023
Q1
$385K Sell
9,429
-4,125
-30% -$178K 0.36% 64
2022
Q4
$695K Hold
13,554
0.68% 38
2022
Q3
$593K Hold
13,554
0.65% 42
2022
Q2
$711K Sell
13,554
-675
-5% -$34.4K 0.73% 36
2022
Q1
$737K Sell
14,229
-2,235
-14% -$116K 0.63% 44
2021
Q4
$972K Hold
16,464
0.82% 32
2021
Q3
$708K Buy
16,464
+2,422
+17% +$107K 0.64% 38
2021
Q2
$550K Sell
14,042
-264
-2% -$10.3K 0.5% 53
2021
Q1
$518K Buy
14,306
+419
+3% +$14.9K 0.5% 57
2020
Q4
$511K Buy
+13,887
New +$509K 0.51% 47

Other funds holding PFE

Signature Wealth Management Partners's PFE Position: Q2 2025 in Review

Signature Wealth Management Partners sold out of Pfizer (PFE) in Q2 2025, closing a stake of 16,529 shares — an estimated $419K sold.

Signature Wealth Management Partners first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $972K in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Signature Wealth Management Partners reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Signature Wealth Management Partners sold 16,529 Pfizer shares in Q2 2025, an estimated $419K.
  • Signature Wealth Management Partners first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
  • Signature Wealth Management Partners's Pfizer position peaked at $972K in Q4 2021.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Signature Wealth Management Partners's 13F filing for Q2 2025, filed 22 Jul 2025.